John Michael Middlecott Banham, Director at Cyclacel Pharmaceuticals, Inc. (CYCC), bought 3,500 shares at $5.86 ($21K) on 2006-09-07, disclosed to the SEC on 2006-09-08.
Open-market purchase of $21k CYCC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| IVZ | SELL | 2012-08-28 | $55K | — | Filing → |